Role of Proton Pump Inhibitor as Stress Ulcer Prophylaxis in Sick Children: A Randomized Controlled Trial

被引：0
|
作者：
Ananya Kavilapurapu [1 ]
AV Lalitha [1 ]
Santu Ghosh [2 ]
机构：
[1] St. John’s Medical College and Hospital,Department of Pediatric Critical Care
[2] St. John’s Medical College and Hospital,Department of Biostatistics
来源：
Indian Pediatrics | 2025年 / 62卷 / 6期
关键词：
Critically ill children; PPI; Stress ulcer prophylaxis; Pantoprazole; GI bleeding;
D O I：
10.1007/s13312-025-00035-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：407 / 413
页数：6
相关论文
共 50 条
  • [41] Intravenous proton-pump inhibitor for acute peptic ulcer bleeding -: is profound acid supression beneficial to reduce the risk of rebleeding?
    Garrido, A.
    Giraldez, A.
    Trigo, C.
    Leo, E.
    Guil, A.
    Marquez, J. L.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2008, 100 (08) : 466 - 469
  • [42] Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies
    He, Na
    Yan, Yingying
    Su, Shan
    Ge, Qinggang
    Zhai, Suodi
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (09) : 988 - 997
  • [43] Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multicentered, randomized controlled clinical trial
    Xia Li
    Haomeng Wu
    Beihua Zhang
    Ting Chen
    Xiaoshuang Shi
    Jinxin Ma
    Jiaqi Zhang
    Xudong Tang
    Fengyun Wang
    Trials, 23
  • [44] Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multicentered, randomized controlled clinical trial
    Li, Xia
    Wu, Haomeng
    Zhang, Beihua
    Chen, Ting
    Shi, Xiaoshuang
    Ma, Jinxin
    Zhang, Jiaqi
    Tang, Xudong
    Wang, Fengyun
    TRIALS, 2022, 23 (01)
  • [45] Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial)
    Vcev, A
    Vceva, A
    Kurbel, S
    Takac, B
    Stimac, D
    Ivandic, A
    Ostojic, R
    Barbir, A
    Hovat, D
    Mihaljevic, S
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 (23-24) : 939 - 941
  • [46] Pediatric intensive care stress ulcer prevention (PIC-UP): A protocol for a pilot randomized trial
    Duffett M.
    Choong K.
    Foster J.
    Gilfoyle E.
    Lacroix J.
    Pai N.
    Thabane L.
    Cook D.J.
    Pilot and Feasibility Studies, 3 (1)
  • [47] Rates of Stress Ulcer Prophylaxis Deprescribing in Children Receiving Usual versus High-Dose Corticosteroids in the Pediatric Intensive Care Unit with Status Asthmaticus
    Parman, Avery
    Miller, Jamie L.
    Neely, Stephen
    Johnson, Peter N.
    Gupta, Neha
    HOSPITAL PHARMACY, 2024, 59 (06) : 677 - 683
  • [48] Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients—protocol for a systematic review with meta-analysis and trial sequential analysis
    Søren Marker
    Anders Perner
    Jørn Wetterslev
    Marija Barbateskovic
    Janus Christian Jakobsen
    Mette Krag
    Anders Granholm
    Carl Thomas Anthon
    Morten Hylander Møller
    Systematic Reviews, 6
  • [49] Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients: A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
    Krag M.
    Perner A.
    Wetterslev J.
    Wise M.P.
    Hylander Møller M.
    Intensive Care Medicine, 2014, 40 (1) : 11 - 22
  • [50] Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation - results from two randomized controlled studies
    Sharma, P.
    Shaheen, N. J.
    Perez, M. C.
    Pilmer, B. L.
    Lee, M.
    Atkinson, S. N.
    Peura, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (07) : 731 - 741
12345